Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques. We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
The global healthcare landscape is currently undergoing a paradigm shift. Eastern Medicine Techniques, once viewed as "alternative," have now entered the mainstream of integrative medicine. According to recent industrial data, the global herbal medicine market is projected to reach USD 430 billion by 2028. This growth is driven by a rising demand for natural treatments, preventive care, and the holistic approach offered by Traditional Chinese Medicine (TCM).
Modern Eastern Medicine Techniques are no longer limited to manual decoctions. They now involve high-precision extraction, AI-driven molecular analysis, and standardized industrial manufacturing. As a leading manufacturer, we utilize Single Herb Granules technology to ensure that the chemical profile of our extracts matches those found in traditional brews, but with enhanced safety and portability.
Our industrial advantage lies in the integration of AI-monitored extraction systems. By controlling temperature, pressure, and time at a micro-level, we ensure that active ingredients like ginsenosides or flavonoids are preserved at their highest potency. This technological leap has positioned China as the global hub for TCM granule exporting.
Global pharmaceutical procurement is moving toward clean-label and traceable ingredients. Major buyers in Europe and North America now require "Fingerprint Identification" for herbal extracts. This trend has made TCM granules the preferred choice because of their standardized concentration (e.g., 5:1 or 10:1 ratios) and consistency across batches.
The B2B demand for Eastern Medicine has shifted from raw herbs to "Ready-to-Dispense" systems. Clinics in London, New York, and Sydney are increasingly adopting automated dispensing machines that use our standardized granules to create custom patient formulas in seconds, replacing the hours needed for traditional boiling.
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation.
As a “National Enterprise Technology Center”, “High-tech Enterprise” and “National Key Leading Enterprise in Agricultural Industrialization”, NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
Clinical Integration: In the West, TCM granules are used to supplement conventional cancer treatments or manage chronic pain. Our Formula Herb Granules are easily soluble in water, making them perfect for patients who find traditional herbal tea difficult to consume.
Health & Wellness Industry: Beyond clinics, the nutraceutical industry incorporates our powders into functional foods, energy bars, and high-end skincare products. The purity of our extracts ensures they meet the stringent heavy metal and pesticide residue regulations of the EU and FDA.
B2B Bulk Export: We operate as a high-capacity OEM/ODM partner for global herbal brands. Whether it is individualized prescription granules for a local practitioner or bulk containers for a large-scale distributor, our supply chain ensures timely delivery and cost-efficiency.
Neo-Green Herbs
